OPPENHEIMER & CO INC - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 117 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
OPPENHEIMER & CO INC ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$206,000
-9.6%
60,6830.0%0.01%
-16.7%
Q2 2018$228,000
-13.3%
60,683
-5.5%
0.01%
-14.3%
Q1 2018$263,000
-12.6%
64,238
-0.6%
0.01%
-12.5%
Q4 2017$301,000
-33.6%
64,638
+1.4%
0.01%
-33.3%
Q3 2017$453,000
-10.8%
63,738
-9.2%
0.01%
-14.3%
Q2 2017$508,000
+51.6%
70,221
+29.1%
0.01%
+55.6%
Q1 2017$335,000
-17.7%
54,405
-21.7%
0.01%
-25.0%
Q4 2016$407,000
+16.3%
69,516
+5.5%
0.01%
+20.0%
Q3 2016$350,000
-15.0%
65,916
+5.8%
0.01%
-16.7%
Q2 2016$412,000
+66.8%
62,316
+18.0%
0.01%
+50.0%
Q1 2016$247,000
-6.4%
52,816
+1.0%
0.01%0.0%
Q4 2015$264,000
+83.3%
52,316
+27.7%
0.01%
+100.0%
Q3 2015$144,000
-86.8%
40,966
-62.6%
0.00%
-86.7%
Q2 2015$1,092,000
-22.2%
109,390
-0.8%
0.03%
-21.1%
Q1 2015$1,403,000
-3.0%
110,232
+7.9%
0.04%
-9.5%
Q4 2014$1,446,000
-4.7%
102,181
-7.4%
0.04%
-6.7%
Q3 2014$1,517,000
-31.1%
110,291
-22.9%
0.04%
-31.8%
Q2 2014$2,201,000
+34.6%
143,107
+49.2%
0.07%
+34.7%
Q1 2014$1,635,000
+9.4%
95,943
-16.9%
0.05%
+2.1%
Q4 2013$1,495,000
+23.9%
115,467
-3.5%
0.05%
+14.3%
Q3 2013$1,207,000
+144.3%
119,678
+80.9%
0.04%
+121.1%
Q2 2013$494,00066,1750.02%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Foresite Capital Management I, LLC 1,312,006$16,990,00016.50%
VHCP Management, LLC 1,000,273$12,954,0006.97%
Cormorant Asset Management, LP 1,700,000$22,015,0006.39%
HARVEY CAPITAL MANAGEMENT INC 890,500$11,531,0004.76%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 859,672$11,133,0002.50%
Rhenman & Partners Asset Management AB 400,000$5,180,0002.03%
SECTORAL ASSET MANAGEMENT INC 2,758,950$35,728,0001.54%
NORTHPOINTE CAPITAL LLC 1,289,711$16,701,0001.47%
Knoll Capital Management, LLC 200,000$2,592,0001.30%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,483,260$19,208,0001.00%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders